The initial reporter stated they received discrepant results for one patient sample tested with elecsys ft3 iii on two cobas 8000 e 801 modules, a cobas 8000 e 602 module, and a cobas e 411 immunoassay analyzer.The results measured at the customer site were reported outside of the laboratory to a physician.Refer to the attachment for all patient data.The sample was initially tested on the customer's e 801 analyzer on (b)(6) 2021.The sample was repeated on a siemens centaur analyzer.The sample was also provided for investigation where it was tested on an e 602 analyzer and an e411 analyzer on (b)(6) 2021.The sample was repeated on a second e 801 analyzer used for investigation on (b)(6) 2021.The serial number of the customer's e 801 analyzer is (b)(4).The ft3 reagent lot number and expiration date used on this analyzer was requested, but not provided.The serial number of the e 801 analyzer used for investigation is (b)(4).Ft3 reagent lot number 476059, with an expiration date of 31-aug-2021 was used on this analyzer.The serial number of the e 602 analyzer used for investigation is (b)(4).Ft3 reagent lot number 473372, with an expiration date of 31-may-2021 was used on this analyzer.The serial number of the e411 analyzer used for investigation is (b)(4).Ft3 reagent lot number 473372, with an expiration date of 31-may-2021 was used on this analyzer.
|
Further investigations of the patient sample determined that the sample contains an interfering factor against the streptavidin component of the ft3 assay.An interfering factor to the ft3 antibody/idiotype could not be identified in the sample.Product labeling states: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.".
|